Schedule 13G ownership disclosure
FUSION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 36118A100
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 15.0300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001623632-24-000039
- Form type
- SC 13G
- Filer
- FEDERATED HERMES, INC.
- CIK
- CIK 1056288
- Filed
- Jan 18, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership